DIRS.INFO The most relevant business & tech news

Dec 5 (Reuters) - Eli Lilly (LLY.N) on Tuesday said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month for customers whose health insurance does not cover the drug, or half the list price. Wall Street analysts expect sales of Zepbound to reach about $2 billion in 2024, and for sales of Novo Nordisk's (NOVOb.CO) rival obesity drug Wegovy to hit around $7.5 billion. An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. When the U.S. Food and Drug Administration approved Zepbound in November, Lilly said it would launch after the U.S. Thanksgiving holiday. Lilly's obesity drug has the same active ingredient, tirzepatide, as its previously approved diabetes drug Mounjaro, which has been used off-label for weight loss since its 2022 launch.

Persons: Eli Lilly, Wegovy, danuglipron, Zepbound, Lilly, Mike Segar, Eli Lilly's, Patrick Wingrove, Manas Mishra, Khushi, Arun Koyyur, Alexander Smith, Bill Berkrot Organizations: Wall Street, Novo, Pfizer, Company, REUTERS, CVS, U.S . Food, Drug Administration, U.S, Thomson Locations: U.S, Branchburg , New Jersey, Indianapolis, New York, Bengaluru

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsNov 29 (Reuters) - Microsoft will take a non-voting, observer position on OpenAI's board, CEO Sam Altman said in his first official missive after taking back the reins of the company on Wednesday. The observer position means Microsoft's representative can attend OpenAI's board meetings and access confidential information, but it does not have voting rights on matters including electing or choosing directors. The new OpenAI board is on an active search for six new members with expertise in fields from technology to safety and policy. OpenAI's chief scientist Ilya Sutskever will no longer be part of the board, Altman said. Apart from Altman, Brockman, Sutskever, D'Angelo, OpenAI's previous board consisted of entrepreneur Tasha McCauley, Helen Toner, director of strategy at Georgetown's Center for Security and Emerging Technology.

Persons: Dado Ruvic, Sam Altman, Satya Nadella, Altman, OpenAI, Bret Taylor, Larry Summers, Adam D'Angelo, Mira Murati, Greg Brockman, Greg, Ilya Sutskever, Sutskever, Ilya, Brockman, D'Angelo, OpenAI's, Tasha McCauley, Helen Toner, Akanksha, Krystal Hu, Sayantani Ghosh, Stephen Coates Organizations: REUTERS, Microsoft, U.S . Treasury, Reuters, Georgetown's Center for Security, Emerging Technology, Thomson Locations: OpenAI, Bengaluru, New York, San Francisco

☆ Medical device maker Medtronic raises fiscal 2024 profit view
▼ + stars: | 2023-11-21 | by ( ) www.reuters.com time to read: +1 min

Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. Medtronic joins medical device makers including Abbott Laboratories (ABT.N) and Boston Scientific(BSX.N) that have benefited from soaring demand for non-urgent surgeries. It now expects profit to be between $5.13 per share and $5.19 per share for the fiscal year 2024, above the range of $5.08 per share to $5.16 per share expected previously. On an adjusted basis, the Dublin-based company reported a profit of $1.25 per share for the second quarter, above analysts' average estimate of $1.18 per share, according to LSEG data. Reporting by Khushi Mandowara and Christy Santhosh in Bengaluru; Editing by Pooja DesaiOur Standards: The Thomson Reuters Trust Principles.

Persons: Dado Ruvic, Medtronic, Khushi Mandowara, Christy Santhosh, Pooja Desai Organizations: REUTERS, Abbott, Abbott Laboratories, Boston, Thomson Locations: Dublin, Bengaluru

LONDON, Nov 21 (Reuters) - The shares and bonds of CPI Property Group (O5G.DE) fell sharply on Tuesday after short-selling hedge fund Muddy Waters said it had bet against the credit of the Luxembourg-based commercial landlord. In a report, seen by Reuters, the fund said CPI Property Group's controlling shareholder, Czech billionaire Radovan Vitek, had misstated the value of the company. CPI Property Group's Frankfurt-listed shares were last down 2.8% on the day, while the price of its 2027 medium-term note fell 3.5 cents on the day to 70.259, data from Tradeweb showed. Muddy Waters did not specify against which bond it had taken a short position and the company has several outstanding notes listed. CPI Property Group owns properties in Germany, the Czech Republic, Poland and elsewhere in Central and Eastern Europe.

Persons: Muddy Waters, Radovan Vitek, Nell Mackenzie, Amanda Cooper, Jason Neely Organizations: CPI, Reuters, Group's, CPI Property Group, Thomson Locations: Muddy, Luxembourg, Czech, Group's Frankfurt, Tradeweb, Germany, Czech Republic, Poland, Central, Eastern Europe

☆ US FDA to delay decision on Bristol Myers-2seventy bio cancer therapy
▼ + stars: | 2023-11-20 | by ( ) www.reuters.com time to read: +2 min

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The U.S. Food and Drug Administration (FDA) has not yet confirmed when the advisory panel would meet, they added. Shares of Bristol Myers Squibb fell more than 2% and those of 2seventy bio slid nearly 20% in early morning trade. The therapy was originally co-developed by bluebird bio (BLUE.O) but following its spin-off in 2021 became part of 2seventy's portfolio. Bristol Myers and 2seventy bio, however, have faced manufacturing constraints, and a month-long planned maintenance shutdown of one of Abecma's manufacturing facility in June had also negatively impacted sales.

Persons: Andrew Kelly, 2seventy bio's, Bristol Myers, Johnson, Biotech's, Khushi, Sriraj Kalluvila Organizations: Food and Drug Administration, FDA, REUTERS, Bristol Myers Squibb, U.S . Food, Drug Administration, Bristol, Johnson, Thomson Locations: White Oak , Maryland, U.S, Bengaluru

☆ U.S., Israel and Hamas reach tentative deal to pause conflict and free dozens of hostages- WaPo
▼ + stars: | 2023-11-19 | by ( ) www.reuters.com time to read: +1 min

Smoke rises after an Israeli airstrike in Gaza, as seen from southern Israel, amid the ongoing conflict between Israel and the Palestinian group Hamas, November 18, 2023. REUTERS/Alexander Ermochenko/File Photo Acquire Licensing RightsNov 18 (Reuters) - Israel, the United States and Hamas have reached a tentative agreement to free dozens of women and children held hostage in Gaza in exchange for a five-day pause in fighting, the Washington Post reported on Saturday, citing people familiar with the deal. Hamas took about 240 hostages during its Oct. 7 rampage inside Israel that killed 1,200 people. There was no immediate comment from the White House or the Israeli prime minister's office on the Post report. Reporting by Akanksha Khushi in Bengaluru and Doina Chiacu in Washington; Editing by Chizu NomiyamaOur Standards: The Thomson Reuters Trust Principles.

Persons: Alexander Ermochenko, Akanksha, Chizu Organizations: Palestinian, Hamas, REUTERS, Washington Post, Thomson Locations: Gaza, Israel, United States, Bengaluru, Doina, Washington

An upswing in the use of GLP-1 drugs has had a notable impact on the higher growth of pharmacy benefit costs under such health insurance plans, Mercer said. GLP-1 drugs, which work by suppressing hunger and making a person feel full longer, are typically priced around $1,000 per patient per month. While employers cover the use of GLP-1 drugs as a treatment for diabetes, the debate around providing coverage for them as an obesity treatment lingers. "It may take another couple of years for price increases stemming from higher healthcare sector wages and medical supply costs to be felt across all health plans." Despite rising health-plan costs, large employers have avoided shifting additional costs to employees through higher deductibles, co-pays, or out-of-pocket maximums in 2023.

Persons: Victoria Klesty, Mercer, Health Actuary, Sunit Patel, Eli Lilly's, Patel, Beth Umland, Khushi Mandowara, Leroy Leo, Pooja Desai Organizations: REUTERS, U.S . Food, Drug, Health, Reuters, Novo Nordisk's, Mercer, Thomson Locations: Oslo, Norway, August31, Victoria, United States, Bengaluru

REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsNov 15 (Reuters) - The U.S. health regulator's staff on Wednesday flagged concerns that data on Merck's (MRK.N) chronic cough drug might not be enough to prove the treatment's meaningful benefit, documents released ahead of a meeting of independent experts showed. The concerns were raised after the company had submitted additional efficacy data to the U.S. Food and Drug Administration (FDA), which declined to approve the drug in January last year. A panel of expert advisers to the FDA is set to meet on Friday to discuss the efficacy of Merck's drug gefapixant. Staff assessment of the data submitted by Merck showed a small reduction in cough frequency and side effects such as loss of taste in patients who were administered the drug. The European Union and Japan have approved Merck's drug for the condition and it is sold under the brand name Lyfnua.

Persons: Brendan McDermid, Mara Goldstein, Christy Santhosh, Shinjini Ganguli, Anil D'Silva, Shailesh, Shounak Organizations: Merck, Co, REUTERS, U.S . Food, Drug Administration, FDA, Staff, European Union, Thomson Locations: Rahway , New Jersey, U.S, United States, Japan, Bengaluru

☆ EU agrees law to hit fossil fuel imports with methane emissions limit
▼ + stars: | 2023-11-15 | by ( ) www.reuters.com time to read: +1 min

Nov 15 (Reuters) - The European Union reached a deal early Wednesday on a law to place methane emissions limits on Europe's oil and gas imports from 2030, pressuring international suppliers to clamp down on leaks of the potent greenhouse gas. After all-night talks, negotiators from EU member states and the European Parliament agreed to a law which from 2030 will require importers of crude oil, gas and coal into Europe to prove those fuels meet a methane intensity limit. The law will now be put to the European Parliament and EU countries for final approval. "Equivalent monitoring, reporting and verification measures should be applied by exporters to the EU by 1 January 2027, and maximum methane intensity values by 2030," the EU Council said in a statement. The regulation also introduces new requirements for the oil, gas and coal sectors to measure, report and verify methane emissions, the EU council said in a statement.

Persons: Akanksha Khushi, Gerry Doyle Organizations: European Union, EU, Thomson Locations: Europe, Bengaluru

☆ Brokerage firm BTIG accuses rival StoneX of stealing technology
▼ + stars: | 2023-11-14 | by ( ) www.reuters.com time to read: +1 min

Nov 13 (Reuters) - U.S. brokerage firm BTIG on Monday filed a lawsuit against rival StoneX Group Inc (SNEX.O), accusing it of stealing trade secrets, and sought at least $200 million in damages. "Defendant StoneX recruited a team of BTIG traders and software engineers to exfiltrate BTIG software code and proprietary information and take it to StoneX," lawyers for BTIG wrote in the suit filed in the California Superior Court, San Francisco County. StoneX used the software code and proprietary information to build competing products and business lines "that generate tens of millions of dollars annually," they said. StoneX did not immediately respond to a Reuters' request for comment outside of regular business hours. BTIG's lawyers also requested the court issue an injunction to prevent StoneX from using or disclosing BTIG's trade secrets or other proprietary information.

Persons: Defendant StoneX, BTIG, StoneX, Akanksha, Blake Brittain, Stephen Coates Organizations: StoneX, California Superior Court, Thomson Locations: California, San Francisco County, Bengaluru, Washington

The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. Following the data, yields on short-term UK Gilts, reflecting near-term interest rate expectations, slid, aiding a 7.0% surge in rate sensitive real estate investment trusts (.FTNMX351020). "It may well be due to potential sentiment coming ahead of tomorrow's UK CPI data, with the hope that it comes in lower as well," said Christopher Peters, trading floor manager at Accendo Markets. UK October CPI data, due on Wednesday, could throw further light on the outlook for domestic monetary policy. Reporting by Khushi Singh and Johan M Cherian in Bengaluru; Editing by Sherry Jacob-Phillips and Alex RichardsonOur Standards: The Thomson Reuters Trust Principles.

Persons: Toby Melville, Christopher Peters, Jefferies, Tim Clark, Khushi Singh, Johan M Cherian, Sherry Jacob, Phillips, Alex Richardson Organizations: London Stock Exchange Group, City of, REUTERS, Vodafone, Federal, tomorrow's, Accendo Markets, Investors, Entain, Royce, Emirates, Thomson Locations: City, City of London, Britain, Teck, U.S, Italy, Bengaluru

☆ London stocks slip on sluggish GDP data, Diageo's profit warning
▼ + stars: | 2023-11-10 | by ( Khushi Singh | ) www.reuters.com time to read: +2 min

The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. The exporter-focused FTSE 100 (.FTSE) was down 0.9% at 0932 GMT, while the mid-cap FTSE 250 (.FTMC) dropped 2.2%, on track for the biggest one-day fall since early July. The broader beverages index (.FTNMX451010) fell 11.0%, touching the lowest levels since March 2021 and was on track for its biggest one-day decline in over 36 years. Meanwhile, data showed the British economic output failed to grow in the July-to-September period, but at least managed to avoid the start of a recession. Reporting by Khushi Singh in Bengaluru; Editing by Eileen Soreng and Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.

Persons: Toby Melville, Johnnie Walker, Khushi Singh, Eileen Soreng Organizations: London Stock Exchange Group, City of, REUTERS, FTSE, Diageo, Bank of England, Bank of, Victoria, U.S . Federal, Thomson Locations: City, City of London, Britain, America, Caribbean, Bengaluru

☆ GM to halt production of Cruise driverless van
▼ + stars: | 2023-11-07 | by ( ) www.reuters.com time to read: +1 min

[1/2] FILE PHOTO: A Cruise self-driving car, which is owned by General Motors Corp, is seen outside the company’s headquarters in San Francisco, California, U.S., September 26, 2018. REUTERS/Heather Somerville/File Photo/File Photo Acquire Licensing RightsNov 6 (Reuters) - General Motors (GM.N) is finishing production on a small number of its pre-commercial fully autonomous van the Cruise Origin, after which the automaker plans to temporarily pause its production, a company spokesperson told Reuters on Monday. The Cruise Origin vehicle was jointly developed by GM, Cruise and Honda. The move comes after Cruise, the driverless car unit of General Motors, suspended all operations nationwide after California regulators ordered the robotaxi operator to remove its driverless cars from state roads. California regulators suspended the company's license to operate driverless vehicles last month, saying self-driving vehicles were a risk to the public.

Persons: Heather Somerville, Forbes, Kyle Vogt's, Vogt, Cruise, Akanksha Khushi, Mrinmay Dey, Nivedita Bhattacharjee, Dhanya Ann Thoppil Organizations: General Motors Corp, REUTERS, General Motors, GM, Cruise, Honda, Thomson Locations: San Francisco , California, U.S, Japan, Tokyo, California, Bengaluru

☆ Bristol Myers buys Orum's blood cancer therapy for up to $180 mln
▼ + stars: | 2023-11-06 | by ( ) www.reuters.com time to read: 1 min

A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo Acquire Licensing RightsNov 6 (Reuters) - Bristol Myers Squibb (BMY.N) has acquired Orum Therapeutics' experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday. The therapy, ORM-6151, which helps degrade a specific protein hard to treat previously, has received the U.S. Food and Drug Administration's (FDA) clearance for an early stage study. The deal includes an upfront payment of $100 million and milestone payments, Orum said, without disclosing further details. Reporting by Khushi Mandowara in Bengaluru; Editing by Dhanya Ann Thoppil and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.

Persons: Brian Snyder, Orum, Khushi, Dhanya Ann Thoppil Organizations: Bristol Myers Squibb, REUTERS, Orum Therapeutics, U.S . Food, Thomson Locations: Cambridge , Massachusetts, U.S, Bengaluru

☆ Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say
▼ + stars: | 2023-11-01 | by ( Khushi Mandowara | ) www.reuters.com time to read: +3 min

Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken, November 27, 2021. Around 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach $2 billion in 2023 sales from the private market, a figure four analysts told Reuters was achievable. The company has said it expects total U.S. COVID vaccine demand to be as much as 100 million doses in the fall season. Moderna forecast $6 billion to $8 billion for sales of its COVID-19 vaccine in 2023, $2 billion to $4 billion of which is expected to come from the commercial market. The COVID vaccine is Cambridge, Massachusetts-based Moderna's lone marketed product.

Persons: Dado Ruvic, Oppenheimer, Hartaj Singh, Michael Yee, Yee, Manas Mishra, Khushi, Patrick Wingrove, Bill Berkrot Organizations: REUTERS, Reuters, U.S, Moderna, Pfizer, Jefferies, GSK, Thomson Locations: Cambridge , Massachusetts, United States, Bengaluru, New

☆ Humana shares fall as reaffirmed 2023 profit view disappoints
▼ + stars: | 2023-11-01 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. The health insurer stuck to its 2023 adjusted profit target of at least $28.25 per share. As of Sept. 30, 5.9 million members were enrolled in its Medicare Advantage plans, up 14.7% from a year ago. The company raised its forecast for 2023 Medicare Advantage membership for the second time this year, and now expects to add at least 860,000 people. It reported a quarterly adjusted profit of $7.78 per share, beating analysts' estimate of $7.16 per share.

Persons: Andrew Kelly, Humana, Julie Utterback, Utterback, UnitedHealth, Khushi, Milla Nissi Organizations: Humana Inc, REUTERS, Wednesday, Health, Humana, Medicare, Thomson Locations: Queens , New York City, U.S, Bengaluru

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Sales of Paxlovid and the vaccine Pfizer makes with German partner BioNTech (22UAy.DE) had boosted revenue to record levels the last two years. Reuters GraphicsPfizer continues to expect 2023 revenue growth of 6%-8% from non-COVID products, with a majority occurring in the second half. Paxlovid sales slumped 97% in the third quarter to $202 million, while vaccine revenue of $1.31 billion was down from $4.4 billion a year earlier. Analysts had expected $1.44 billion for the vaccine and $618.20 million from Paxlovid, according to LSEG data.

Persons: Wolfgang Rattay, Evan Seigerman, BioNTech, Albert Bourla, Angela Hwang, Paxlovid, Bhanvi Satija, Michael Erman, Sriraj Kalluvila, Bill Berkrot Organizations: REUTERS, Pfizer, BMO Capital, Reuters Graphics Pfizer, GSK, CVS, Analysts, U.S ., Thomson Locations: Europe, Paxlovid, Bengaluru, New York

☆ Pfizer swings to quarterly loss as COVID product demand slump sparks charges
▼ + stars: | 2023-10-31 | by ( ) www.reuters.com time to read: +3 min

The company recorded a $5.6 billion charge in the third quarter related to Paxlovid and vaccine Comirnaty, most of which was disclosed earlier this month. Paxlovid sales slumped 97% in the third quarter to $202 million, while vaccine revenue came in at $1.31 billion, down from $4.4 billion a year earlier. Analysts had expected sales of $1.44 billion for the vaccine and $618.20 million for Paxlovid, according to LSEG data. Sales of its recently launched respiratory syncytial virus (RSV) vaccine, Abrysvo, came in at $375 million for the quarter. Overall revenue was $13.23 billion, compared to $22.64 billion a year earlier.

Persons: Wolfgang Rattay, Evan Seigerman, Bhanvi Satija, Michael Erman, Sriraj Organizations: REUTERS, Pfizer, U.S, BioNTech, Analysts, BMO Capital, U.S ., Thomson Locations: Bengaluru, New York

☆ Aurelius in talks to buy The Body Shop, source says
▼ + stars: | 2023-10-29 | by ( Akanksha Khushi | ) www.reuters.com time to read: +1 min

The logo of British cosmetics and skin care company The Body Shop is seen outside a store in Vienna, Austria, June 4, 2016. REUTERS/Leonhard Foeger/File Photo Acquire Licensing RightsOct 29 (Reuters) - Private equity investor Aurelius Group is in talks to buy beauty products chain The Body Shop, which has been put up for sale by its Brazilian owner Natura & Co (NTCO3.SA), a source familiar with the talks told Reuters. If completed, the deal is expected to value The Body Shop at a lower price than the 400 million pounds-500 million pounds ($485.20 million-$606.50 million) suggested in some media reports, the source, who did not wish to be identified, said. Natura bought The Body Shop from L'Oreal (OREP.PA) in 2017. Natura and Aurelius declined to comment while The Body Shop did not immediately respond to requests for comment.

Persons: Leonhard Foeger, Aurelius, Akanksha, Alexander Smith, Susan Fenton Organizations: REUTERS, Natura, Reuters, L'Oreal, Sky News, Thomson Locations: Vienna, Austria, Brazilian, Bengaluru

☆ Two Sigma tells clients of $620 million in unexpected gains, losses, Wall Street Journal reports
▼ + stars: | 2023-10-29 | by ( ) www.reuters.com time to read: 1 min

Oct 29 (Reuters) - Hedge fund Two Sigma Investments has told clients of $620 million in unexpected gains and losses which resulted from unauthorized adjustments, the Wall Street Journal reported. The Securities and Exchange Commission (SEC) is examining the matter, Sunday's WSJ report added, citing sources. The SEC declined to comment on the WSJ report when approached by Reuters. Two Sigma did not immediately respond to requests for a response. Reporting by Akanksha Khushi in Bengaluru; Editing by Alexander SmithOur Standards: The Thomson Reuters Trust Principles.

Persons: Akanksha, Alexander Smith Organizations: Sigma Investments, Wall Street Journal, The Securities, Exchange Commission, SEC, Reuters, Sigma, Thomson Locations: Bengaluru

☆ J&J says DoJ seeking information related to eye products in civil investigation
▼ + stars: | 2023-10-27 | by ( ) www.reuters.com time to read: 1 min

The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing RightsOct 27 (Reuters) - Johnson & Johnson (JNJ.N) disclosed on Friday that the U.S. Department of Justice (DOJ) in July had sought documents and information related to the drugmaker's free and discounted eye surgery products in connection with a civil investigation. The company said it had begun complying with the DoJ's civil investigative demands. J&J said it is in ongoing discussion with DOJ regarding the inquiry. Reporting by Khushi Mandowara in Bengaluru; Editing by Shailesh KuberOur Standards: The Thomson Reuters Trust Principles.

Persons: Johnson, Yves Herman, J, Khushi, Shailesh Organizations: Johnson, REUTERS, U.S . Department of Justice, Thomson Locations: Brussels, Diegem, Belgium, Bengaluru

☆ London stocks slip as downbeat earnings weigh
▼ + stars: | 2023-10-26 | by ( ) www.reuters.com time to read: +1 min

The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. REUTERS/Toby Melville/File Photo Acquire Licensing RightsSummaryCompanies FTSE 100 down 0.8%, FTSE 250 off 0.6%Oct 26 (Reuters) - The UK's FTSE 100 edged lower on Thursday as Standard Chartered led a slide in bank stocks and Unilever led a drop in consumer shares after the two blue-chip companies posted disappointing earnings. The FTSE 100 (.FTSE) declined 0.8% by 0709 GMT, while the mid-cap FTSE 250 (.FTMC) dipped 0.6%, extending losses to a third straight day. Shares of Standard Chartered (STAN.L) dropped 12.8%, the most on the FTSE 100, after the UK lender flagged a 33% drop in pre-tax profit in the third quarter. The Dove soap maker's shares fell 3.1%, while the personal care, drug and grocery stores index (.FTNMX452010) lost 1.9%.

Persons: Toby Melville, Khushi Singh, Savio D'Souza Organizations: London Stock Exchange Group, City of, REUTERS, Chartered, Unilever, FTSE, Standard Chartered, WPP, Thomson Locations: City, City of London, Britain

☆ India to resume some visa services in Canada
▼ + stars: | 2023-10-25 | by ( ) www.reuters.com time to read: +1 min

A large India national flag is attached to India House where the High Commission of India is located, in London, Britain, September 19 2023. REUTERS/Peter Nicholls/File Photo Acquire Licensing RightsOct 25 (Reuters) - India will resume some visa services in Canada with effect from Oct. 26, its High Commission said on Wednesday, in a move that could reduce tensions caused by the murder of a Sikh separatist leader in Canada. On Wednesday, the Indian High Commission said it had decided to resume issuing some categories of visas after reviewing the security situation and taking into account recent Canadian measures, which it did not enumerate. It said it would resume issuing standard entry visas as well as business, medical and conference visas. Reporting by Akanksha Khushi in Bengaluru; Editing by Toby Chopra and Kevin LiffeyOur Standards: The Thomson Reuters Trust Principles.

Persons: Peter Nicholls, Justin Trudeau, Hardeep Singh Nijjar, Akanksha, Toby Chopra, Kevin Liffey Organizations: Commission, REUTERS, Canada, Indian High Commission, Thomson Locations: India, London, Britain, Canada, Canadian, Vancouver, Bengaluru

☆ Stellantis nears deal to buy 20% of Chinese EV maker Leapmotor - Bloomberg News
▼ + stars: | 2023-10-25 | by ( ) www.reuters.com time to read: +2 min

A flag with the logo of Stellantis is seen at the company's corporate office building in Saint-Quentin-en-Yvelines near Paris, France, May 5, 2021. The partnership would also give Stellantis access to the EV maker's parts and certain technologies, according to the report. Stellantis, whose brands include Fiat and Peugeot, has only a very small presence in China, the world's largest auto market. The group and rivals such as Renault (RENA.PA) are concerned about growing competition from cheap Chinese electric cars in Europe. The companies are hammering out the final details of a transaction and an announcement could be made in the coming days, Bloomberg said.

Persons: Gonzalo Fuentes, Stellantis, Leapmotor, Akanksha, Gilles Guillaume, Giulio Piovaccari, Zhang Yan, Keith Weir, Shilpi Majumdar, Shweta Agarwal, Mike Harrison, Jan Harvey Organizations: REUTERS, Stellantis, Bloomberg, Zhejiang, HK, Fiat, Peugeot, Renault, Hong Kong, Guangzhou Automobile Group, Thomson Locations: Saint, Yvelines, Paris, France, China, Europe, Hong Kong, Bengaluru, Milan, Shanghai

☆ Snap sees upbeat fourth quarter as new ad features start to pay off
▼ + stars: | 2023-10-24 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

Revenue for the third quarter ended September rose 5% to $1.19 billion, beating analysts' expectations of $1.11 billion, according to LSEG data. For the fourth quarter, the Santa Monica, California-based company expects revenue to be between $1.32 billion and $1.38 billion. Snap, however, said it saw a risk to its sales in the fourth quarter as a war in the Middle East could tamp down spending from a large number of brand-oriented advertising campaigns. Daily active users on Snapchat were 406 million, beating Wall Street expectations of 405.7 million. Snap's net loss widened to $368 million in the quarter from $360 million a year earlier.

Persons: Dado Ruvic, Scott Kesler, Evan Spiegel, Thomas Monteiro, Khushi, Anil D'Silva Organizations: REUTERS, Revenue, Meta, Investing.com, Thomson Locations: Santa Monica , California, Bengaluru

Search resuls for: "Khushi"

25 mentions found